12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Staphylokinase: Phase III started

Bharat began an open-label, Indian Phase III trial to compare a 30 mL double-bolus of staphylokinase vs. IV streptokinase in about 120 AMI patients. Bharat has an exclusive license...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >